The U.S. Supreme Court rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict the company won against rival drugmaker Gilead Sciences Inc. for infringing a patent in a dispute over a blockbuster hepatitis C treatment.
The U.S. Supreme Court agreed to hear a bid by President Donald Trump’s administration to revive pilot programs adopted by the states of Arkansas and New Hampshire that allow work requirements to be imposed on people who receive healthcare under the Medicaid program for the poor.
U.S. health authorities will hold an emergency meeting to recommend that a coronavirus vaccine awaiting approval be given first to healthcare professionals and people in long-term care facilities.
Join TLD Group Advisor and Senior Consultant Dr. Kent Bottles in a webinar on December 3rd that will discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?
U.S. Supreme Court justices signaled they are unlikely to strike down the Obamacare healthcare law in a legal challenge brought by Texas and 17 other Republican-governed states and joined by President Donald Trump’s administration.
Join this webinar for a compelling presentation from TLD Group Advisor and Senior Consultant Dr. Kent Bottles who discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?
Missouri’s highest court refused to consider Johnson & Johnson’s appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products.
The U.S. Supreme Court ruled that a 2003 law does not violate constitutional free speech rights by requiring overseas affiliates of American-based nonprofit groups that seek federal funding for HIV/AIDS relief to take a formal stance opposing prostitution and sex trafficking.
The U.S. Supreme Court considered a bid by Donald Trump’s administration to implement rules allowing employers to obtain religious exemptions from an Obamacare requirement that health insurance that they provide to employees covers women’s birth control.
The U.S. Supreme Court ruled in favor of health insurers seeking $12 billion from the federal government under a program set up by the Obamacare law aimed at encouraging them to offer medical coverage to previously uninsured Americans.